SKINNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SkinHealth Systems Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$10.55−0.01 (-0.09%)
Close on Oct 19, 2026
- Market cap
- $1.37B
- P/E (TTM)
- –
- Dividend yield
- –
SkinHealth Systems Inc. revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Consumables | $53.86M | $46.37M | $57.68M | $49.84M | $55.83M | $49.36M | $56.70M | $51.19M | $55.39M | $45.62M | $52.18M | $46.37M | 74.7% | -3.5% |
| Delivery Systems | $18.25M | $18.54M | $24.69M | $20.82M | $22.36M | $20.22M | $26.80M | $27.61M | $35.21M | $35.78M | $44.64M | $51.04M | 25.3% | -18.4% |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Americas | $49.89M | $44.61M | $57.41M | $48.26M | $52.05M | $46.26M | $57.06M | $51.88M | $57.73M | $50.33M | – | – | 69.2% | -4.2% |
| Europe, the Middle East and Africa | $14.92M | $13.74M | $18.83M | $16.06M | $18.42M | $14.99M | $17.21M | $16.10M | $19.23M | $19.11M | $18.77M | $21.05M | 20.7% | -19.0% |
| Asia-Pacific | $7.30M | $6.57M | $6.13M | $6.34M | $7.72M | $8.34M | $9.23M | $10.83M | $13.64M | $11.97M | $18.67M | $24.66M | 10.1% | -5.4% |
| United States | – | – | – | – | – | – | – | $51.88M | $57.73M | $50.33M | $59.38M | $51.70M | – | – |
From the segment and revenue-disaggregation notes of SkinHealth Systems's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.